Myocardial Infarction following Administration of Sublingual Ergotamine
Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following l...
Gespeichert in:
| Veröffentlicht in: | Chest 1982-09, Vol.82 (3), p.375-376 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 376 |
|---|---|
| container_issue | 3 |
| container_start_page | 375 |
| container_title | Chest |
| container_volume | 82 |
| creator | Klein, Lawrence S. Simpson, Ross J. Stem, Robert Hayward, Jean C. Foster, James R. |
| description | Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine. We feel that the ergotamine was an important precipitating cause in both infarctions. |
| doi_str_mv | 10.1378/chest.82.3.375 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_13662724</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369215417076</els_id><sourcerecordid>13662724</sourcerecordid><originalsourceid>FETCH-LOGICAL-c285t-7261a10163236ff69450148581773a35bb6f7462a1d57abd4755602d8885d1543</originalsourceid><addsrcrecordid>eNp1kLtPwzAYxC0EKqWwsiF1YkvwI35krKpSKhUxALPl2E4xSuJiJ6D-97gPsTF9-nS_O-kOgFsEc0S4eNAfNva5wDnJCadnYIxKgjJCC3IOxhAinBFW4ktwFeMnTD8q2QiMOIJUMDEGy-ed1yoYp5rpqqtV0L3z3bT2TeN_XLeZzkzrOhf7oA6Cr6evQ9UkZUiORdj4XiXAXoOLWjXR3pzuBLw_Lt7mT9n6Zbmaz9aZxoL2GccMKQQRI5iwumZlQSEqBBWIc6IIrSpW84JhhQzlqjIFp5RBbIQQ1KBUagLuj7nb4L-GVF22LmrbNKqzfogSEcYwx3swP4I6-BiDreU2uFaFnURQ7peTh-WkwJLItFwy3J2Sh6q15g8_TZV0cdRtqvftbJBRO9tpa1ywupfGu_-ifwGqQXzx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13662724</pqid></control><display><type>article</type><title>Myocardial Infarction following Administration of Sublingual Ergotamine</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Klein, Lawrence S. ; Simpson, Ross J. ; Stem, Robert ; Hayward, Jean C. ; Foster, James R.</creator><creatorcontrib>Klein, Lawrence S. ; Simpson, Ross J. ; Stem, Robert ; Hayward, Jean C. ; Foster, James R.</creatorcontrib><description>Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine. We feel that the ergotamine was an important precipitating cause in both infarctions.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.82.3.375</identifier><identifier>PMID: 7105868</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Oral ; Adult ; Ergotamine - administration & dosage ; Ergotamine - adverse effects ; Ergotamine - therapeutic use ; Female ; Humans ; Migraine Disorders - drug therapy ; Mouth Floor ; Myocardial Infarction - chemically induced</subject><ispartof>Chest, 1982-09, Vol.82 (3), p.375-376</ispartof><rights>1982 The American College of Chest Physicians</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c285t-7261a10163236ff69450148581773a35bb6f7462a1d57abd4755602d8885d1543</citedby><cites>FETCH-LOGICAL-c285t-7261a10163236ff69450148581773a35bb6f7462a1d57abd4755602d8885d1543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7105868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klein, Lawrence S.</creatorcontrib><creatorcontrib>Simpson, Ross J.</creatorcontrib><creatorcontrib>Stem, Robert</creatorcontrib><creatorcontrib>Hayward, Jean C.</creatorcontrib><creatorcontrib>Foster, James R.</creatorcontrib><title>Myocardial Infarction following Administration of Sublingual Ergotamine</title><title>Chest</title><addtitle>Chest</addtitle><description>Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine. We feel that the ergotamine was an important precipitating cause in both infarctions.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Ergotamine - administration & dosage</subject><subject>Ergotamine - adverse effects</subject><subject>Ergotamine - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Migraine Disorders - drug therapy</subject><subject>Mouth Floor</subject><subject>Myocardial Infarction - chemically induced</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtPwzAYxC0EKqWwsiF1YkvwI35krKpSKhUxALPl2E4xSuJiJ6D-97gPsTF9-nS_O-kOgFsEc0S4eNAfNva5wDnJCadnYIxKgjJCC3IOxhAinBFW4ktwFeMnTD8q2QiMOIJUMDEGy-ed1yoYp5rpqqtV0L3z3bT2TeN_XLeZzkzrOhf7oA6Cr6evQ9UkZUiORdj4XiXAXoOLWjXR3pzuBLw_Lt7mT9n6Zbmaz9aZxoL2GccMKQQRI5iwumZlQSEqBBWIc6IIrSpW84JhhQzlqjIFp5RBbIQQ1KBUagLuj7nb4L-GVF22LmrbNKqzfogSEcYwx3swP4I6-BiDreU2uFaFnURQ7peTh-WkwJLItFwy3J2Sh6q15g8_TZV0cdRtqvftbJBRO9tpa1ywupfGu_-ifwGqQXzx</recordid><startdate>198209</startdate><enddate>198209</enddate><creator>Klein, Lawrence S.</creator><creator>Simpson, Ross J.</creator><creator>Stem, Robert</creator><creator>Hayward, Jean C.</creator><creator>Foster, James R.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>198209</creationdate><title>Myocardial Infarction following Administration of Sublingual Ergotamine</title><author>Klein, Lawrence S. ; Simpson, Ross J. ; Stem, Robert ; Hayward, Jean C. ; Foster, James R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c285t-7261a10163236ff69450148581773a35bb6f7462a1d57abd4755602d8885d1543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Ergotamine - administration & dosage</topic><topic>Ergotamine - adverse effects</topic><topic>Ergotamine - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Migraine Disorders - drug therapy</topic><topic>Mouth Floor</topic><topic>Myocardial Infarction - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klein, Lawrence S.</creatorcontrib><creatorcontrib>Simpson, Ross J.</creatorcontrib><creatorcontrib>Stem, Robert</creatorcontrib><creatorcontrib>Hayward, Jean C.</creatorcontrib><creatorcontrib>Foster, James R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klein, Lawrence S.</au><au>Simpson, Ross J.</au><au>Stem, Robert</au><au>Hayward, Jean C.</au><au>Foster, James R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myocardial Infarction following Administration of Sublingual Ergotamine</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>1982-09</date><risdate>1982</risdate><volume>82</volume><issue>3</issue><spage>375</spage><epage>376</epage><pages>375-376</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><abstract>Ergotamine is commonly used in the treatment of migraine headache. Since migraine may be associated with variant angina, some patients with migraine may develop coronary ischemia following therapy with ergotamine. We describe a young woman with migraine who had two myocardial infarctions following low dose sublingual ergotamine. We feel that the ergotamine was an important precipitating cause in both infarctions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7105868</pmid><doi>10.1378/chest.82.3.375</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-3692 |
| ispartof | Chest, 1982-09, Vol.82 (3), p.375-376 |
| issn | 0012-3692 1931-3543 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_13662724 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Administration, Oral Adult Ergotamine - administration & dosage Ergotamine - adverse effects Ergotamine - therapeutic use Female Humans Migraine Disorders - drug therapy Mouth Floor Myocardial Infarction - chemically induced |
| title | Myocardial Infarction following Administration of Sublingual Ergotamine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A19%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myocardial%20Infarction%20following%20Administration%20of%20Sublingual%20Ergotamine&rft.jtitle=Chest&rft.au=Klein,%20Lawrence%20S.&rft.date=1982-09&rft.volume=82&rft.issue=3&rft.spage=375&rft.epage=376&rft.pages=375-376&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1378/chest.82.3.375&rft_dat=%3Cproquest_cross%3E13662724%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13662724&rft_id=info:pmid/7105868&rft_els_id=S0012369215417076&rfr_iscdi=true |